Cardiorenal syndrome type 2: from diagnosis to optimal management

References

• RoncoCHaapioMHouseAAAnavekarNBellomoRCardiorenal syndromeJ Am Coll Cardiol200852191527153919007588
   PubMed Web of Science ®Google Scholar
• RoncoCMcCulloughPAnkerSDAcute Dialysis Quality Initiative (ADQI) consensus groupCardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiativeEur Heart J201031670371120037146
   PubMed Web of Science ®Google Scholar
• RoncoCHouseAAHaapioMCardiorenal syndrome: refining the definition of a complex symbiosis gone wrongIntensive Care Med200834595796218251008
   PubMed Web of Science ®Google Scholar
• SchrierRWCardiorenal versus renocardiac syndrome: is there a difference?Nat Clin Pract Nephrol200731263718033224
   PubMedGoogle Scholar
• MooreEMBellomoRNicholADThe meaning of acute kidney injury and its relevance to intensive care and anaesthesiaAnaesth Intensive Care201240692994823194202
   PubMed Web of Science ®Google Scholar
• KrumholzHMChenYTVaccarinoVCorrelates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failureAm J Cardiol20008591110111310781761
   PubMed Web of Science ®Google Scholar
• CioffiGTarantiniLPulignanoGPrevalence, predictors and prognostic value of acute impairment in renal function during intensive unloading therapy in a community population hospitalized for decompensated heart failureJ Cardiovasc Med (Hagerstown)20078641942717502758
   PubMed Web of Science ®Google Scholar
• De VecchisRCiccarelliAArianoCRenoprotective effect of small volumes of hypertonic saline solution in chronic heart failure patients with marked fluid retention: results of a case-control studyHerz20113611217 German20978728
   PubMed Web of Science ®Google Scholar
• CruzDNSchmidt-OttKMVescovoGPathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI)Contrib Nephrol201318211713623689659
   PubMed Web of Science ®Google Scholar
• BagshawSMCruzDNAspromonteNAcute Dialysis Quality Initiative Consensus GroupEpidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus ConferenceNephrol Dial Transplant20102551406141620185818
   PubMed Web of Science ®Google Scholar
• AghelAShresthaKMullensWBorowskiATangWHSerum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failureJ Card Fail2010161495420123318
   PubMed Web of Science ®Google Scholar
• AmsalemYGartyMSchwartzRPrevalence and significance of unrecognized renal insufficiency in patients with heart failureEur Heart J20082981029103618339607
   PubMed Web of Science ®Google Scholar
• WaikarSSBonventreJVCreatinine kinetics and the definition of acute kidney injuryJ Am Soc Nephrol200920367267919244578
   PubMed Web of Science ®Google Scholar
• KjeldsenLJohnsenAHSengeløvHBorregaardNIsolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinaseJ Biol Chem19932681410425104327683678
   PubMed Web of Science ®Google Scholar
• MishraJDentCTarabishiRNeutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgeryLancet200536594661231123815811456
   PubMed Web of Science ®Google Scholar
• RoosJFDoustJTettSEKirkpatrickCMDiagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children–a meta-analysisClin Biochem2007405–638339117316593
   PubMed Web of Science ®Google Scholar
• StevensLACoreshJSchmidCHEstimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKDAm J Kidney Dis200851339540618295055
   PubMed Web of Science ®Google Scholar
• MacdonaldJMarcoraSJibaniMGFR estimation using cystatin C is not independent of body compositionAm J Kidney Dis200648571271917059990
   PubMed Web of Science ®Google Scholar
• VaidyaVSRamirezVIchimuraTBobadillaNABonventreJVUrinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injuryAm J Physiol Renal Physiol20062902F517F52916174863
   PubMed Web of Science ®Google Scholar
• ParikhCRAbrahamEAncukiewiczMEdelsteinCLUrine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unitJ Am Soc Nephrol200516103046305216148039
   PubMed Web of Science ®Google Scholar
• LiangosOPerianayagamMCVaidyaVSUrinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failureJ Am Soc Nephrol200718390491217267747
   PubMed Web of Science ®Google Scholar
• MaiselASMuellerCFitzgeraldRPrognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trialEur J Heart Fail201113884685121791540
   PubMed Web of Science ®Google Scholar
• GottliebSSAbrahamWButlerJThe prognostic importance of different definitions of worsening renal function in congestive heart failureJ Card Fail20028313614112140805
   PubMed Web of Science ®Google Scholar
• MetraMNodariSParrinelloGWorsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significanceEur J Heart Fail200810218819518279773
   PubMed Web of Science ®Google Scholar
• MacFadyenRJNg Kam ChuenMJDavisRCLoop diuretic therapy in left ventricular systolic dysfunction: has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy?Eur J Heart Fail201012764965220576834
   PubMed Web of Science ®Google Scholar
• TestaniJMMcCauleyBDKimmelSEShannonRPCharacteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failureAm J Cardiol2010106121763176921055713
   PubMed Web of Science ®Google Scholar
• TestaniJMMcCauleyBDChenJShumskiMShannonRPWorsening renal function defined as an absolute increase in serum creatinine is a biased metric for the study of cardio-renal interactionsCardiology2010116320621220689277
   PubMed Web of Science ®Google Scholar
• TestaniJMChenJMcCauleyBDKimmelSEShannonRPPotential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survivalCirculation2010122326527220606118
   PubMed Web of Science ®Google Scholar
• SmithGLLichtmanJHBrackenMBRenal impairment and outcomes in heart failure: systematic review and meta-analysisJ Am Coll Cardiol200647101987199616697315
   PubMed Web of Science ®Google Scholar
• LucasCJohnsonWHamiltonMAFreedom from congestion predicts good survival despite previous class IV symptoms of heart failureAm Heart J2000140684084711099986
   PubMed Web of Science ®Google Scholar
• De VecchisREspositoCArianoCCantatrioneSHypertonic saline plus i.v. furosemide improve renal safety profile and clinical outcomes in acute decompensated heart failure: A meta-analysis of the literatureHerz Epub2014330
   PubMed Web of Science ®Google Scholar
• BrandimarteFMuredduGFBoccanelliADiuretic therapy in heart failure: current controversies and new approaches for fluid removalJ Cardiovasc Med (Hagerstown)201011856357020186069
   PubMed Web of Science ®Google Scholar
• EzekowitzJAHernandezAFStarlingRCStandardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF)Am Heart J2009157221922819185628
   PubMed Web of Science ®Google Scholar
• HowardPADunnMIEffectiveness of continuous infusions of loop diuretics for severe heart failureJ Cardiovasc Med (Hagerstown)20067151016645354
   PubMed Web of Science ®Google Scholar
• LetoLAspromonteNFeolaMContinuous infusion versus bolus injection of loop diuretics in acute heart failure: a literature reviewG Ital Cardiol (Rome)2012134263272 Italian22495643
   PubMedGoogle Scholar
• FelkerGMLeeKLBullDANHLBI Heart Failure Clinical Research NetworkDiuretic strategies in patients with acute decompensated heart failureN Engl J Med2011364979780521366472
   PubMed Web of Science ®Google Scholar
• LiangKVWilliamsAWGreeneELRedfieldMMAcute decompensated heart failure and the cardiorenal syndromeCrit Care Med2008361 SupplS75S8818158481
   PubMedGoogle Scholar
• CostanzoMRGuglinMESaltzbergMTUNLOAD Trial InvestigatorsUltrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failureJ Am Coll Cardiol200749667568317291932
   PubMed Web of Science ®Google Scholar
• ShahSUAnjumSLittlerWAUse of diuretics in cardiovascular diseases: (1) heart failurePostgrad Med J20048094220120515082840
   PubMed Web of Science ®Google Scholar
• KazoryARossEAContemporary trends in the pharmacological and extracorporeal management of heart failure: a nephrologic perspectiveCirculation2008117797598318285578
   PubMed Web of Science ®Google Scholar
• ButlerJFormanDEAbrahamWTRelationship between heart failure treatment and development of worsening renal function among hospitalized patientsAm Heart J2004147233133814760333
   PubMed Web of Science ®Google Scholar
• KnightELGlynnRJMcIntyreKMMogunHAvornJPredictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD)Am Heart J19991385 Pt 184985510539815
   PubMed Web of Science ®Google Scholar
• KazoryAUltrafiltration does not affect certain predictors of outcome in heart failureInt J Cardiol201014311320207034
   PubMed Web of Science ®Google Scholar
• FiaccadoriERegolistiGMaggioreUUltrafiltration in heart failureAm Heart J2011161343944921392597
   PubMed Web of Science ®Google Scholar
• RavidMLangRRachmaniRLishnerMLong-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up studyArch Intern Med199615632862898572838
   PubMedGoogle Scholar
• De VecchisRCiccarelliAPucciarelliAUnloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon?J Cardiovasc Med (Hagerstown)201011857157420588135
   PubMed Web of Science ®Google Scholar
• ReillyTSchorkMRVasopressin antagonists: Pharmacotherapy for the treatment of heart failureAnn Pharmacother201044468068720332337
   PubMed Web of Science ®Google Scholar
• PackerMMcMurrayJMassieBMClinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot studyJ Card Fail2005111122015704058
   PubMed Web of Science ®Google Scholar
• WittelesRMKaoDChristophersonDImpact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trialJ Am Coll Cardiol200750191835184017980248
   PubMed Web of Science ®Google Scholar
• van DeursenVMHernandezAFStebbinsANesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF)Circulation20141301295896525074507
   PubMed Web of Science ®Google Scholar
• NoviaskyJAKelbermanMWhalenKMGuharoyRDarkoWScience or fiction: use of nesiritide as a first-line agent?Pharmacotherapy20032381081108312921256
   PubMed Web of Science ®Google Scholar
• GheorghiadeMKonstamMABurnettJCEfficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) InvestigatorsShort-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status TrialsJAMA2007297121332134317384438
   PubMed Web of Science ®Google Scholar
• KonstamMAGheorghiadeMBurnettJCJrEfficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) InvestigatorsEffects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome TrialJAMA2007297121319133117384437
   PubMed Web of Science ®Google Scholar
• KalraPRMoonJCCoatsAJDo results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?Int J Cardiol2002852–319519712208583
   PubMed Web of Science ®Google Scholar
• GalièNRubinLJHoeperMTreatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trialLancet200837196302093210018572079
   PubMed Web of Science ®Google Scholar
• MetraMCotterGDavisonBARELAX-AHF InvestigatorsEffect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomesJ Am Coll Cardiol201361219620623273292
   PubMed Web of Science ®Google Scholar
• NeverovaNTeerlinkJRSerelaxin: a potential new drug for the treatment of acute heart failureExpert Opin Investig Drugs201423710171026
   PubMed Web of Science ®Google Scholar
• CostanzoMRUltrafiltration in the management of heart failureCurr Opin Crit Care200814552453018787444
   PubMed Web of Science ®Google Scholar
• WertmanBMGuraVSchwarzERUltrafiltration for the management of acute decompensated heart failureJ Card Fail200814975475918995180
   PubMed Web of Science ®Google Scholar
• HuntSAAbrahamWTChinMHAmerican College of Cardiology FoundationAmerican Heart Association2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung TransplantationJ Am Coll Cardiol20095315e1e9019358937
   PubMed Web of Science ®Google Scholar
• McMurrayJJAdamopoulosSAnkerSDTask Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of CardiologyESC Committee for Practice GuidelinesESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEur J Heart Fail201214880386922828712
   PubMed Web of Science ®Google Scholar
• BartBABoyleABankAJUltrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trialJ Am Coll Cardiol200546112043204616325039
   PubMed Web of Science ®Google Scholar
• RogersHLMarshallJBockJA randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failureJ Card Fail20081411518226766
   PubMed Web of Science ®Google Scholar
• GiglioliCLandiDCecchiEEffects of ULTRAfiltration vs DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO studyEur J Heart Fail201113333734621131387
   PubMed Web of Science ®Google Scholar
• BartBAGoldsmithSRLeeKLHeart Failure Clinical Research NetworkUltrafiltration in decompensated heart failure with cardiorenal syndromeN Engl J Med2012367242296230423131078
   PubMed Web of Science ®Google Scholar
• De VecchisREspositoCArianoCEfficacy and safety assessment of isolated ultrafiltration compared to intravenous diuretics for acutely decompensated heart failure: a systematic review with meta-analysisMinerva Cardioangiol201462213114624686993
   PubMed Web of Science ®Google Scholar
• CostanzoMRSaltzbergMTJessupMTeerlinkJRSobotkaPAUltrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure (UNLOAD) InvestigatorsUltrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOADJ Card Fail201016427728420350693
   PubMed Web of Science ®Google Scholar
• BradleySMLevyWCVeenstraDLCost-consequences of ultrafiltration for acute heart failure: a decision model analysisCirc Cardiovasc Qual Outcomes20092656657320031894
   PubMed Web of Science ®Google Scholar